Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular edema.
Glaucoma is a group of diseases that damage the eye’s optic nerve and can, if left untreated, cause vision impairment and even blindness. Glaucoma is asymptomatic (meaning it occurs without noticeable symptoms appearing). It can often go undiagnosed without proper check-ups and can get worse over time. Although the development of glaucoma is not completely understood, we do know that it damages the nerve fibers in the optic nerve and in the retina, limiting a person’s field of view and quality of...